David P Nowotnik - Net Worth and Insider Trading

David P Nowotnik Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David P Nowotnik owns 1 companies in total, including Abeona Therapeutics Inc (ABEO) .

Click here to see the complete history of David P Nowotnik’s form 4 insider trades.

Insider Ownership Summary of David P Nowotnik

Ticker	Comapny	Transaction Date	Type of Owner
ABEO	Abeona Therapeutics Inc	2008-05-21	Sr Vice President R&D

David P Nowotnik Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David P Nowotnik Ownership Network

Ownership Network List of David P Nowotnik

No Data

Ownership Network Relation of David P Nowotnik

David P Nowotnik Owned Company Details

What does Abeona Therapeutics Inc do?

Who are the key executives at Abeona Therapeutics Inc?

David P Nowotnik is the Sr Vice President R&D of Abeona Therapeutics Inc. Other key executives at Abeona Therapeutics Inc include Chief Financial Officer Christine Berni Silverstein , SVP & General Counsel Brendan M. O'malley , and director & Chief Executive Officer Vishwas Seshadri .

Abeona Therapeutics Inc (ABEO) Insider Trades Summary

Over the past 18 months, David P Nowotnik made no insider transaction in Abeona Therapeutics Inc (ABEO). Other recent insider transactions involving Abeona Therapeutics Inc (ABEO) include a net sale of 40,177 shares made by Mark Alvino , a net purchase of 50,000 shares made by Vishwas Seshadri , and a net sale of 6,173 shares made by Michael Amoroso .

In summary, during the past 3 months, insiders sold 0 shares of Abeona Therapeutics Inc (ABEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 94,077 shares of Abeona Therapeutics Inc (ABEO) were sold and 88,758 shares were bought by its insiders, resulting in a net sale of 5,319 shares.

Abeona Therapeutics Inc (ABEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Abeona Therapeutics Inc Insider Transactions

No Available Data

David P Nowotnik Mailing Address

Above is the net worth, insider trading, and ownership report for David P Nowotnik. You might contact David P Nowotnik via mailing address: Access Pharmaceuticals Inc, 2600 Stemmons Frwy Ste 176, Dallas Tx 752072107.

Discussions on David P Nowotnik

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.